Eli Lilly & Co Diabetes Research

New Treatment for Hypoglycemia Gets FDA Approval

A new method for raising glucose levels

Diabetes is a disease often characterized by high blood sugar, but low blood sugar can be extremely dangerous as well.

Low blood sugar often occurs as the result of insulin injections or other medications aimed at lowering glycogen levels.

But if this happens too rapidly, it can cause hypoglycemia, a condition which can cause death quickly if left untreated.

To treat this ailment the FDA recently approved a new method of raising glucose levels.

The low blood sugar treatment, created by Eli Lilly and Co, involves getting the hormone glucagon into the body, via the nose. It is the first treatment of this kind that does not involve an injection.

Hypoglycemia is a very dangerous condition that can threaten anyone who requires insulin or other medication to lower blood sugar. It is not to be taken lightly, but it is great to see more and more options become available in case the emergency arises.

Back to blog